These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 3817924

  • 1. Autoantibodies to intermediate filaments in acute viral hepatitis.
    Chandra M, Golani DD, Sachdeva S, Bihari N, Sharma DK.
    Indian J Med Res; 1986 Sep; 84():247-51. PubMed ID: 3817924
    [No Abstract] [Full Text] [Related]

  • 2. Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin.
    Brown C, Pedersen J, Underwood JR, Gust I, Toh BH.
    J Clin Lab Immunol; 1986 Jan; 19(1):1-4. PubMed ID: 3084793
    [Abstract] [Full Text] [Related]

  • 3. [Clinical aspects of severe forms of serum hepatitis type B].
    Ketiladze ES, Farber NA, Zhilina NN, Vorozhbieva TE, Savitskiĭ GI.
    Klin Med (Mosk); 1980 Jan; 58(1):46-52. PubMed ID: 6966013
    [No Abstract] [Full Text] [Related]

  • 4. [Analysis of the clinical forms of hepatitis B in light of the viral-immunogenetic concept of its pathogenesis].
    Sorinson SN, Korochkina OV, Iakhontov NE.
    Sov Med; 1984 Jan; (5):27-30. PubMed ID: 6463720
    [No Abstract] [Full Text] [Related]

  • 5. [T- and B-lymphocytes, M, A and G immunoglobulins in viral hepatitis, liver cirrhosis and HBs-Ag carrier state].
    Belozerov ES, Sagandikov BB, Shabalin VV.
    Klin Med (Mosk); 1979 Mar; 57(3):63-5. PubMed ID: 312361
    [No Abstract] [Full Text] [Related]

  • 6. Autoimmunity in chronic liver disease caused by hepatitis delta virus.
    Zauli D, Crespi C, Bianchi FB, Craxi A, Pisi E.
    J Clin Pathol; 1986 Aug; 39(8):897-9. PubMed ID: 3745480
    [Abstract] [Full Text] [Related]

  • 7. [Effect of disappearance of HBs antigen from the blood serum of patients with acute hepatitis B on the level of immunoglobulins G, A and M and selected laboratory studies].
    Rzeszowska G, Patorska-Mach E, Mierzejewska I.
    Pol Tyg Lek; 1979 Nov 26; 34(48):1862-4. PubMed ID: 530882
    [No Abstract] [Full Text] [Related]

  • 8. Levamisole treatment of acute viral hepatitis and HBsAG-positive chronic active hepatitis.
    Pár A, Barna K, Bajtai G, Hollós I, Ambrus M, Kovács M, Jávor T.
    Acta Med Acad Sci Hung; 1980 Nov 26; 37(3):269-81. PubMed ID: 7457030
    [Abstract] [Full Text] [Related]

  • 9. Autoantibodies to intermediate filaments in experimental infections with Trypanosoma brucei gambiense.
    Anthoons JA, Van Marck EA, Gigase PL.
    Z Parasitenkd; 1986 Nov 26; 72(4):443-52. PubMed ID: 3529673
    [Abstract] [Full Text] [Related]

  • 10. [Clinico-biochemical characteristics of HBsAG-negative acute hepatitis B].
    Mkhitarian AL, Ketiladze ES, Nemtsova EB, Braginskiĭ DM, Viazov SO.
    Sov Med; 1989 Nov 26; (7):87-9. PubMed ID: 2799540
    [No Abstract] [Full Text] [Related]

  • 11. Immune response in acute viral hepatitis.
    Berg PA.
    Clin Gastroenterol; 1974 May 26; 3(2):255-75. PubMed ID: 4278836
    [No Abstract] [Full Text] [Related]

  • 12. [G and M immunoglobulins during acute hepatitis. Quantitative and qualitative studies].
    Berthold H, Stiess G.
    Zentralbl Bakteriol Orig A; 1974 May 26; 227(1-4):368-71. PubMed ID: 4154613
    [No Abstract] [Full Text] [Related]

  • 13. What you need to know: interpreting hepatitis B viral markers.
    Tan CK.
    Singapore Med J; 1998 Mar 26; 39(3):139-40. PubMed ID: 9632977
    [No Abstract] [Full Text] [Related]

  • 14. [Kinetics of HBsAg serum level and kinetics of the level of complement as well as of IgG, IgA anf IgM in various forms of viral hepatitis of the B type].
    Loch T.
    Przegl Epidemiol; 1978 Mar 26; 32(4):417-28. PubMed ID: 734129
    [No Abstract] [Full Text] [Related]

  • 15. [The HbsAg/IgM complex in chronic hepatitis B].
    Stránský J, Zichová M, Vodák M.
    Vnitr Lek; 1988 Apr 26; 34(4):371-5. PubMed ID: 3394262
    [No Abstract] [Full Text] [Related]

  • 16. [Immunologic mechanisms of cell damage and pathogenetic correlations in acute and chronic hepatitis].
    Realdi G, Alberti A, Trevisan A, Bortolotti F, Tremolada F, Rigoli AM.
    Minerva Med; 1978 Aug 18; 69(38):2555-67. PubMed ID: 309565
    [No Abstract] [Full Text] [Related]

  • 17. [Lipid values and immune parameters in the course of viral hepatitis in patients with alcohol abuse and without alcohol stress in anamnesis].
    Boroń P, Sokolewicz-Bobrowska E, Boroń-Kaczmarska A, Borzuchowska A, Szpakowicz T.
    Dtsch Z Verdau Stoffwechselkr; 1984 Aug 18; 44(6):270-7. PubMed ID: 6335426
    [Abstract] [Full Text] [Related]

  • 18. [Importance of the immune system in the symptom-free HBsAg carrier state].
    Mansurov KhKh, Asfandiiarova NS.
    Klin Med (Mosk); 1984 Jun 18; 62(6):17-21. PubMed ID: 6381874
    [No Abstract] [Full Text] [Related]

  • 19. [Delta agent infection and immunoglobulin G in acute HBsAg-positive hepatitis with chronic course].
    Tagariello G, Pasquinucci S, Belussi F, Dal Canton A, Alberti A.
    Boll Ist Sieroter Milan; 1987 Jun 18; 66(6):485-8. PubMed ID: 3453151
    [Abstract] [Full Text] [Related]

  • 20. [Surface antigen (HBsAg) and core antigen (HBcAg) of the Dane particle detected by immunofluorescence in hepatic biopsies in patients with acute and chronic hepatitis].
    Rizzetto M, Bonino F, Toselli M, Verme G.
    Minerva Gastroenterol; 1976 Jun 18; 22(3):241-4. PubMed ID: 794760
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.